Realising pharmacists’ full potential

We are working to achieve the 11 key actions in Pharmacists in 2023 to unlock opportunities for pharmacists as the custodians of medicine safety. I was...

PBS listings for cancer, Parkinson’s and motor neurone disease

Since 1 April, medicines crucial to those suffering from cancer, Parkinson’s and motor neurone disease have become available on the Pharmaceutical Benefits Scheme (PBS). The...

Too much asthma reliever

chronic conditions
Asthma is one of the most common chronic conditions in Australia, affecting an estimated one in 10 Australians.1 Despite excellent access to effective pharmacological...

Clinical governance: shared responsibility, a common goal

New principles will help guide design and delivery of high-quality pharmacy services. We have a high-quality health system in Australia, and a first-class pharmacy...

Cardiovascular safety considerations and evidence update in diabetes

cardiovascular
The burden of cardiovascular disease (CVD) in patients with diabetes has long been recognised.1  Learning objectives After reading this article, pharmacists should be able to: Describe...

Medicine safety announced as a National Health Priority Area

Medicine safety has been named a National Health Priority Area at PSA19 this morning, assuring greater focus for pharmacists’ roles in the quality and...